Tangen Biosciences Announces $9 Million Series A Financing to Accelerate Development of Disruptive Molecular Diagnostic Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2WWJ0AZ
via IFTTT